We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

92 hedge funds and large institutions have $60.8M invested in iShares US Pharmaceuticals ETF in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 32 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more call options, than puts

Call options by funds: $1.14M | Put options by funds: $800K

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

3% less funds holding

Funds holding: 95 → 92 (-3)

15.08% less ownership

Funds ownership: 81.14% → 66.05% (-15%)

31% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 32

37% less capital invested

Capital invested by funds: $96.2M → $60.8M (-$35.4M)

Holders
92
Holders Change
-3
Holders Change %
-3.16%
% of All Funds
2.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
22
Reduced
32
Closed
11
Calls
$1.14M
Puts
$800K
Net Calls
+$344K
Net Calls Change
+$693K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.05M
2
RJA
Raymond James & Associates
Florida
+$2.64M
3
SRSA
S.R. Schill & Associates
Washington
+$1.46M
4
CG
Cutler Group
California
+$424K
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$281K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$15.1M
2
Fisher Asset Management
Fisher Asset Management
Washington
-$5.4M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$3.29M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.45M
5
Bank of America
Bank of America
North Carolina
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
CFGS
51
Concourse Financial Group Securities
Alabama
$118K -$2.27K -45 -2%
CF
52
Centaurus Financial
California
$108K +$121K +2,400 New
AA
53
Advisory Alpha
Michigan
$104K +$50.8K +1,008 +93%
US Bancorp
54
US Bancorp
Minnesota
$103K – – –
SFS
55
Sowell Financial Services
Arkansas
$74K – – –
AIC
56
Ameritas Investment Company
Nebraska
$72K +$7.11K +141 +10%
AWA
57
Arkadios Wealth Advisors
Georgia
$62.8K +$303 +6 +0.4%
VFA
58
Valeo Financial Advisors
Indiana
$60K -$2.27K -45 -3%
BFC
59
Bedel Financial Consulting
Indiana
$57K – – –
FANJ
60
Financial Architects (New Jersey)
New Jersey
$52K – – –
PNC Financial Services Group
61
PNC Financial Services Group
Pennsylvania
$50K -$2.27K -45 -4%
Northwestern Mutual Wealth Management
62
Northwestern Mutual Wealth Management
Wisconsin
$49K +$16.9K +336 +45%
GWM
63
Geneos Wealth Management
Colorado
$47K – – –
MAWCM
64
Mine & Arao Wealth Creation & Management
California
$45K – – –
JCM
65
Jacobi Capital Management
Pennsylvania
$44K +$49.2K +975 New
AAMA
66
Advanced Asset Management Advisors
Ohio
$37K -$10.1K -201 -20%
IA
67
IFP Advisors
Florida
$35K -$4.54K -90 -10%
FCMT
68
Founders Capital Management (Texas)
Texas
$35K – – –
VCP
69
Verus Capital Partners
Arizona
$34K -$303 -6 -0.8%
JHCP
70
Jackson Hole Capital Partners
Oklahoma
$34K – – –
LWM
71
Liberty Wealth Management
California
$33K +$151 +3 +0.4%
SF
72
Synovus Financial
Georgia
$31K +$35.7K +708 New
CAAS
73
Capital Asset Advisory Services
Michigan
$30K +$29.8K +591 +6,567%
GRP
74
Global Retirement Partners
California
$28K +$151 +3 +0.5%
ICM
75
Islay Capital Management
Texas
$28K +$31.8K +630 New
1 2
3
4 5

IHE Hedge Fund Activity: Q1 2020 in Review

92 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q1 2020, worth a combined $60.8M — down 37% from $96.2M a quarter earlier.

Fund positioning in IHE was balanced in Q1 2020: 11 funds opened new positions, 11 closed out, 22 added to existing stakes and 32 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $3.05M. The largest seller was Goldman Sachs, cutting an estimated $15.1M.

  • 92 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q1 2020, down from 95 in Q4 2019.
  • Funds reported $60.8M of iShares US Pharmaceuticals ETF stock for Q1 2020, down 37% quarter-over-quarter.
  • 11 funds opened new iShares US Pharmaceuticals ETF positions in Q1 2020 and 11 closed out, a net change of 0 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q1 2020 was Susquehanna International Group, an estimated $3.05M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q1 2020 was Goldman Sachs, an estimated $15.1M sold.

Based on aggregated 13F filings for Q1 2020.